BiotechTube
Home/Advicenne/Linda Law
LL

Linda Law

Former US Vice President, Clinical Development and Medical Affairs

Advicenne

Therapeutic Areas

NephrologyNeurology

Advicenne Pipeline

DrugIndicationPhase
Sibnayal® (ADV7103)Distal Renal Tubular Acidosis (dRTA)Approved / NDA Review
ADV7103CystinuriaPhase 2/3
Sibnayal® (ADV6209)Pediatric Moderate SedationApproved

Leadership Team at Advicenne

PM
Peter Meeus
Chief Executive Officer
PB
Philippe Boucheron
Chairman of the Board of Directors
AU
André Ulmann
Former Interim Chief Executive Officer
View full Advicenne profile